Form 4: Performant Healthcare Director Sells Shares in Merger
Statement of Changes in Beneficial Ownership (Form 4)
Director James LaCamp reports the disposition of all Performant Healthcare shares and restricted stock units due to the company's merger with Continental Buyer, Inc. at $7.75 per share.
Summary
- James LaCamp, a Director of Performant Healthcare Inc. (PHLT), reported changes in beneficial ownership related to the company's merger.
- The transaction date, representing the effective time of the merger, was October 21, 2025.
- Pursuant to the Merger Agreement dated July 31, 2025, Performant Healthcare Inc. merged with Merger Sub, Inc., a wholly-owned subsidiary of Continental Buyer, Inc.
- Performant Healthcare Inc. survived the merger as a wholly-owned subsidiary of Continental Buyer, Inc.
- Each share of Performant Healthcare's Common Stock outstanding immediately prior to the effective time was canceled and converted into the right to receive $7.75 in cash, without interest, subject to withholding taxes.
- Each restricted stock unit (RSU) award, whether vested or unvested, was automatically canceled in consideration for a lump sum cash payment equal to the total number of shares underlying the RSU multiplied by the merger consideration of $7.75.
- Following the reported transaction, James LaCamp beneficially owns 0 shares of Common Stock (down from 417,220) and 0 Restricted Stock Units (down from 35,616).
Sentiment
Score: 5
Explanation: The filing is a factual report of a pre-determined corporate action (merger completion) and the resulting disposition of insider holdings. It does not introduce new information that would significantly alter the sentiment beyond what was already known from the merger announcement.
Positives
- Shareholders of Performant Healthcare Inc. received a definitive cash payment of $7.75 per share, providing liquidity and a clear exit value.
- The merger provides a clear valuation for the company's equity, eliminating market volatility for former shareholders.
Negatives
- Existing shareholders no longer hold equity in Performant Healthcare Inc. and will not participate in any potential future growth or appreciation of the company.
- The company's common stock is no longer publicly traded, removing investment opportunities for public market participants.
Risks
- The filing itself does not detail new risks, but the completion of the merger eliminates the previous investment risks associated with holding Performant Healthcare Inc. common stock, as all equity has been converted to cash.
Future Outlook
The filing does not provide a future outlook for Performant Healthcare Inc. as it has become a wholly-owned subsidiary of Continental Buyer, Inc., and its public shares have been converted to cash.
Industry Context
Mergers and acquisitions are a common strategy in the healthcare industry for consolidation, market expansion, or achieving operational synergies. This transaction signifies a private entity acquiring a publicly traded healthcare company, potentially indicating a strategic move by Continental Buyer, Inc. to expand its footprint or capabilities within the sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Company Status Change | Performant Healthcare Inc. ceased to be a publicly traded company and became a wholly-owned subsidiary of Continental Buyer, Inc. following the merger. | 10/21/2025 | This change significantly alters the corporate governance structure, as the company is no longer subject to public reporting requirements and its board and management will report to the new parent company. |
Stakeholder Impact
- Shareholders: All public shareholders received $7.75 per share in cash, converting their equity investment into a liquid asset.
- Employees: The filing does not detail the impact on employees, but a change in ownership can often lead to organizational restructuring or changes in benefits and compensation.
- Customers and Suppliers: The filing does not detail the impact on customers or suppliers, but the change in ownership could lead to changes in business strategy, product offerings, or supply chain relationships.
Next Steps
- For former shareholders, the next step is to receive the cash consideration for their shares and RSUs as per the merger agreement.
Key Dates
| Date | Description |
|---|---|
| 07/31/2025 | Date of the Agreement and Plan of Merger between Performant Healthcare, Inc., Continental Buyer, Inc., and Prevail Merger Sub, Inc. |
| 10/21/2025 | Date of Earliest Transaction and Effective Time of the Merger, resulting in the conversion of shares and RSUs to cash. |
Recommendation
sellThe company's common stock has been converted into a right to receive $7.75 in cash per share due to the merger. For any remaining shareholders, the recommendation is to 'sell' in the sense of completing the transaction to receive the cash consideration, as there is no longer any publicly traded equity to hold.
Keywords
Performant Healthcare, PHLT, Merger, Acquisition, Form 4, Insider Trading, Director, Stock Disposition, Restricted Stock Units, Continental Buyer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.